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Abstract
Research on the mechanisms underlying circadian rhythmicity and the response of brain and body clocks to environmental
and physiological challenges requires assessing levels of circadian clock proteins. Too often, however, it is difficult to acquire
antibodies that specifically and reliably label these proteins. Many of these antibodies also lack appropriate validation. The
goal of this project was to generate and characterize antibodies against several circadian clock proteins. We examined mice
and hamsters at peak and trough times of clock protein expression in the suprachiasmatic nucleus (SCN). In addition, we
confirmed specificity by testing the antibodies on mice with targeted disruption of the relevant genes. Our results identify
antibodies against PER1, PER2, BMAL1 and CLOCK that are useful for assessing circadian clock proteins in the SCN by
immunocytochemistry.
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Introduction
The suprachiasmatic nucleus (SCN) of the mammalian hypo-
thalamus generates daily rhythms in behavior, hormones and
physiology. The SCN is composed of a heterogeneous population
of neurons which form a functional circadian clock as a result of
coupling through neurochemical interactions [1,2]. Individual cells
from SCN and from many other tissues express 24-hour molecular
rhythmicity that results from a transcriptional-translational feed-
back loop. The transcription factors, CLOCK and BMAL1, form
heterodimers and bind to E-box elements in the promoters of
Period (Per) 1 and Per2, Cryptochrome (Cry) 1 and Cry2 genes. The
protein products of these genes form complexes, which translocate
into the nucleus and interact with the CLOCK/BMAL1 complex,
resulting in repression of their transactivational activity [3,4]. Post-
translational events modify the timing of this negative feedback,
providing fine control over cycle length of the molecular
oscillations [5–10].
Several circadian clock proteins, most notably PER1 and PER2,
have high-amplitude rhythms of abundance in the SCN.
Assessment of these molecular rhythms in the SCN is critical for
understanding the effect of light, drugs, and other interventions on
the phase of the SCN oscillator, and for delineating the impact of
mutations affecting circadian clock function. Several previous
studies have described circadian clock protein rhythms in the SCN
[11–18]. However, it is often difficult to find antibodies that
reliably label clock proteins, and for many commercially available
antibodies, appropriate validation is not available [19].
The goal of this project was to generate and characterize
antibodies against several circadian clock proteins. To this end, we
generated and tested antibodies raised against PER1, PER2,
CLOCK, and BMAL1 in the SCN of mice and hamsters,
identifying antibodies that detect these antigens in the rodent
SCN, and which promise to be useful for other studies of circadian
clock gene products. We did not attempt to quantify the data or
compare differences in staining among antibodies as the various
antibodies were tested at different times. Instead, the results are a
qualitative description of the staining quality obtained for each
antibody studied using three criteria to determine sensitivity and
selectivity with which each antibody appeared to label the
intended antigen. First, immunoreactivity was expected to be
more concentrated in the SCN than in surrounding areas based on
gene expression profiles and other immunocytochemical studies.
Second, SCN staining intensity was expected to be greater at
ZT12 than at ZT0 for PER1 and PER2, as these antigens have
previously been reported to have high-amplitude rhythmic
expression in the SCN [11–18]. Third, immunoreactivity is
expected to be absent in tissues from mice with targeted disruption
of the corresponding gene.
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Antigen sequences
The antigens were recombinant protein fragments, expressed in
bacteria. cDNA constructs encoding fragments of mouse PER2,
CLOCK, BMAL1 in the bacterial expression vector, Novagen
pET-23b (EMD Biosciences, Gibbstown, NJ, USA), were gener-
ously supplied by Dr. Choogon Lee (Florida State University,
Tallahassee, FL, USA), who previously used these constructs to
generate antibodies to these proteins in rats and guinea pigs [5]. A
cDNA fragment encoding a fragment of mouse PER1 was isolated
by reverse-transcription PCR, and directionally subcloned into
pET-23b. The sequence of the insert was verified in both
directions. For each of these constructs, the pET-23b vector
sequence encodes a 14-residue N-terminal epitope
(MASMTGGQQMGRDP), followed by the circadian protein
fragment fused in-frame with the vector sequence that includes the
6His epitope tag. More specifically, translation of the vector added
the C-terminal amino acid sequence PNSSSVDKLAAA-
LEHHHHHH to all proteins except CLOCK. For CLOCK,
the C-terminal sequence was AAALEHHHHHH.
The antigen and residue numbers were as follows: for PER1
(PERIOD1, also called Rigui, BAA94086) residues 1–232 of 1291;
for PER2 (PERIOD2, NP_035196) residues 1–200 of 1257; for
BMAL1 (also known as ARNTL and MOP3; NP_031515),
residues 382–580 (of 626); for CLOCK (AAC53200) residues
363–855 (of 855). In Lee et al. [5], these antigens were called
PERIOD1-1, PERIOD2-1, BMAL1-2, and CLOCK-C.
Antigen Expression and Purification
BL21(De3)pLysS bacteria were transformed, plated on selection
ampicillin/chloramphenicol-containing selection plates and incu-
bated overnight at 37uC. Single bacterial colonies were inoculated
into 100 mL Autoinduction media containing ampicillin and
chloramphenicol (Overnight Express Autoinduction System,
Novagen). Cultures were grown overnight at 37uC with shaking.
The cultures were then centrifuged (2,500 g, 15 minutes, 4uC),
and the pellet was resuspended in guanidinium hydrochloride
denaturing buffer, centrifuged (10,000 g, 20 minutes, 4uC), and
the supernatant was incubated with Talon metal affinity resin
(CLONTECH, Mountain View, CA, USA). After washing,
samples were eluted from gravity columns with Denaturing
Elution Buffer (CLONTECH) following the manufacturer’s
instructions. Samples were then dialyzed overnight in 8 M urea
(Slide-A-Lyzer dialysis cassettes, Pierce Endogen). The purified
proteins were visualized by staining samples separated on 12%
SDS-PAGE gels with Coomassie blue (Biorad, Hercules, CA,
USA).
Regulatory Approvals for Animal Use
All animal studies were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
Animal Welfare regulations. Immunization and bleeding of rabbits
and guinea pigs for generation of antibodies was conducted at
Cocalico Biologicals under protocols approved by their institu-
tional animal care and use committee (protocols 040507CBISTD
and 100407CBISTD). Care and use of Syrian hamsters and wild-
type mice was conducted at Columbia University under protocols
(AC-AAAB0480 and AC-AAAA9505) approved by the Columbia
University Institutional Animal Care and Use Committee. Care
and use of mutant and background-matched mice was conducted
at the University of Massachusetts Medical School under protocols
approved by the UMass Medical School Institutional Animal Care
and Use Committee (protocol A-1572 and A-1315). For studies
involving perfusion fixation, animals were deeply anesthetized
with sodium pentobarbital. In all studies, every effort was made do
minimize stress, discomfort, and pain of the experimental animals.
Animals for Immunization
Antibodies were generated in rabbits and guinea pigs at
Cocalico Biologicals, Inc. (Reamstown, PA, USA). Animals
received an initial immunization in complete Freund’s adjuvant,
and subsequent booster immunizations in incomplete Freund’s
adjuvant. Boosts were administered at 1-month intervals, and
blood samples were collected at 7–10 and 21 days after each boost.
The number of boost-bleed cycles ranged from 2 to 8. For the final
collections, animals were anesthetized and exsanguinated to collect
a larger volume of blood. Blood samples were allowed to clot,
centrifuged, serum samples were frozen, and shipped to UMMS.
Samples were stored at 280uC. Dilutions refer to dilution of crude
serum.
Animals for Immunochemistry
Wild-type animals. Adult male C57BL/6 mice and LVG
Syrian hamsters (Charles River Laboratories, Wilmington, MA,
USA) were group housed (n=3/cage) at Columbia University
with room temperature at 2161uC and ad libitum access to food
and water. A dim red light (,1 lux) used for animal maintenance
was on continuously. Mice were in a 12 hour light: 12 hour dark
(12:12 LD) cycle and were perfused at ZT 0 (the time of lights-on)
or at ZT 12 (the time of lights-off). Hamsters were in a 14:10 LD
cycle and were perfused at ZT 0 (2 hrs before lights-on) or ZT12
(the time of lights-off).
Genetically modified mice and their genetic
controls. Mice with targeted mutations of circadian clock genes
were used to further validate the antibodies. Generation and
characterization of the mutant lines has been previously reported
[13,17,20]. Colonies were maintained at UMass Medical School.
Mice were genotyped by PCR-based amplification of mouse
genomic DNA and gel electrophoresis as previously described
[13,17,20].
Per1
2/2 and Per2
2/2 mice were studied on an sv129 genetic
background, while Bmal1
2/2 and Clock
2/2 mice were studied on a
C57BL/6J genetic background. Mutant mice and control wild-
type mice of the same genetic background were anesthetized and
perfused within 2 hours of lights-out (ZT 12–14) and within
2 hours of lights-on (ZT 0–2) using the procedures described
below. Brains were postfixed overnight, transferred to 20%
sucrose, and then shipped to Columbia University for analysis.
Per1
2/2. Mice with targeted disruption of mPer1 were
generated by Bae et al. [13]. The targeted allele removes exons
2 through 12 of the mouse Per1 gene. This allele was initially called
mPer1
ldc and is more properly called mPer1
tm1drw.
Per2
2/2. Mice with targeted disruption of mPer2 were also
generated by Bae et al. [13]. The targeting event removes exon 5
and a portion of exon 6 of the mouse Per2 gene. This allele was
initially called mPer2
ldc and is more properly called mPer2
tm1drw.I n
some tissues of mice homozygous for this allele, a deletion mutant
form of the PER2 protein is produced. Notably, this mutant
protein was not detected in the SCN of these homozygous mutant
mice by immunocytochemistry [13].
Bmal1
2/2. Mice with targeted disruption of Bmal1 (Mop3 or
Arntl) were generated by Bunger et al. [20]. Founder mice used to
establish our colony were generously provided by Dr. C.A.
Bradfield. Mice homozygous for the targeted allele are also called
BMAL1-deficient mice.
Antibodies to Circadian Clock Proteins
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2/2. Mice with targeted disruption of the Clock gene
(Clock
D5–6 allele, more properly called Clock
tm1.1smr) were generated
by DeBruyne et al. [17]. Mice homozygous for the targeted allele
are also called Clock
2/2, CLOCK-knockout (KO) or CLOCK-
deficient mice.
In previous studies using other antibodies, the SCN of these
mutant lines have been shown to lack immunostaining for the
targeted gene in the SCN. More specifically, Per1
2/2 mice lack
PER1 staining [13], Per2
2/2 mice lack PER2 staining [13],
Bmal1
2/2 mice lack BMAL1 staining [15], and Clock
2/2 mice lack
CLOCK staining in SCN [17].
Perfusion and Fixation
Mice and hamsters were anesthetized (200 mg/kg pentobarbi-
tal, i.p.) at either ZT0 or ZT12. Following deep anesthesia, they
were perfused intracardially with saline (50 or 100 ml for mice or
hamsters, respectively) followed by 4% paraformaldehyde in
0.1 M sodium phosphate buffer (PB; 100 or 200 ml for mice or
hamsters, respectively). Brains were removed and postfixed
overnight, then cryoprotected in 20% sucrose for 2 days.
Immunocytochemistry
Brain sections (50 mm) containing the SCN were cut on a
cryostat at 220uC. Sections were washed 3 times for 10 min with
0.1 M PB containing 0.1% Triton-X-100, blocked for 1 hr with
normal donkey serum (NDS) diluted 1:50 in PB containing 0.3%
Triton followed by incubation in the primary antibodies diluted in
the same buffer. Pilot studies conducted with primary antibodies at
1:5,000 dilution revealed that antibodies made in guinea pig
generally gave more intense signal than antibodies made in rabbit.
Therefore, primary rabbit antibodies were tested at concentrations
of 1:500, 1:1,000 and 1:5,000, while guinea pig antibodies were
tested at 1:1,000, 1:5,000 and 1:10,000. In cases where these
concentrations gave strong background, the guinea pig antibodies
were also tested at 1:20,000 and 1:40,000. After incubation of
primary antibody for 48 hrs at 4uC, sections were washed twice for
10 min, once for 30 min, and once for 10 min in PB+0.1%
Triton, and then were incubated for 2 hr in the appropriate
secondary antibody (donkey anti-rabbit or donkey anti-guinea pig)
conjugated to Cy2 fluorescent chromogen (Jackson ImmunoR-
esearch, West Grove, PA, 1:200 in PB+0.3% Triton). Sections
were washed 3 times for 10 min in PB, mounted, dehydrated and
coverslipped with Krystalon (EM Science, Gibbstown, NJ).
In some cases, one of two different amplification protocols was
performed. In one, a biotinylated secondary antibody was used
(donkey anti-rabbit or anti-guinea pig, 1:200), followed by
incubation in avidin-biotin peroxidase complex (ABC) for 1 hr
(ABC Elite kit, Vector Laboratories, Burlingame, CA, USA;
40 ml/10 ml PB+0.3% Triton). In a second amplification protocol
(ABC+BT), the biotinylated secondary antibody was followed by
incubation in biotinylated tyramine (6 ml/10 ml 0.1 M PB+2 ml
H2O2 for 30 min). Cy2 avidin (1:200 in PB+0.3% Triton) was
used as the fluorescent label.
Analysis of Immunostained Sections
Sections were examined on a Nikon Eclipse E800 microscope
(Nikon, Tokyo, Japan) using Plan-Apo 46,1 0 6 and 206 lenses
with numerical aperture 0.2, 0.45 and 0.75 respectively (Nikon).
Images were captured using QCapture software (version 2.95.0,
Quantitative Imaging, Surrey, BC, Canada) connected to a Q-
Imaging Retiga EXi, fast 1394 camera (Quantitative Imaging). To
evaluate antibody quality and to control for inter-run variability,
sections from mutant animals and their WT controls and those
from ZT12 and ZT0 were processed simultaneously. Subsequent-
ly, images were captured under identical conditions. Images were
imported into Photoshop 7.0 (Adobe Systems Inc., San Jose, CA,
USA) and cropped to show the SCN. Shadows and highlights were
adjusted in the Image-Adjustment-Levels dialog box, by dragging
the black and white Input Levels to the edge of the first group of
pixels on either end of the histogram.
Results
Table 1 provides a list of all antibodies tested and the results of
dilution series conducted at times when levels of the corresponding
antigen were expected to be high in wild-type mice. Table 2 lists
the results of studies conducted at the optimal dilution, comparing
results at expected peak and nadir times, and the results of mutant
mice examined at the peak time. Table 3 summarizes results from
studies examining hamster SCN. Figures 1, 2, and 3 show
photomicrographs of SCN staining for those antibodies producing
strong SCN staining intensity at the concentrations that give the
best labeling. Results for antibodies with poor staining are not
shown in the figures.
For all effective antibodies, the following pattern of staining was
observed. At high concentrations, each antibody produced
relatively ubiquitous staining that was not enriched in the SCN.
At lower concentrations, an optimal signal-to-noise ratio was
achieved. At even lower concentrations, the intensity of staining
was low everywhere.
Antibodies Labeling Mouse SCN
PER1. Both R43 and GP91 worked well in mouse SCN
(Fig. 1, Tables 1, 2).
R43 provided strong staining, specific to SCN cells at ZT12
when used at a 1:5,000 dilution. At ZT 0, stained cells could be
detected, but staining was much weaker than at ZT12 except for a
Table 1. Assessment of Antibody Dilutions in Wild-Type Mice.
Antibody Subjects Antibody Dilutions
Antigen Host
Peak
Time N 1:500 1:1,000 1:5,000 1:10,000
PER1 R43 ZT12 4 + + +++ n.d.
PER1 R1177 ZT12 3 n.d. n.d. ++ n.d
PER1 GP91 ZT12 3 n.d. ++ + + + +
PER2 R38 ZT12 4 ++ + + + +n.d.
PER2 R39 ZT12 5 ++ + + + +n.d.
PER2 GP87 ZT12 3 n.d. ++ + + + +
PER2 GP88 ZT12 5 n.d. ++ + +
BMAL1 R36 ZT0 4 NS NS NS n.d.
BMAL1 R37 ZT0 4 ++ +++ +++ n.d.
BMAL1 GP85 ZT0 4 n.d. ++ + + + +
BMAL1 GP86 ZT0 4 n.d. ++ + + + +
CLOCK R40 ZT12 3 ++ + n.d.
CLOCK R41 ZT12 4 ++ ++ +++ n.d.
Host #: R=rabbit; GP=guinea pig. Peak Time: Wild-type mice were perfused at
the time of expected peak of immunostaining and a series of dilutions was
examined. N=number of animals tested. Results are scored as: 2(no SCN cells
labeled), +(relatively poor staining), ++(good staining in SCN), and +++(best
staining of SCN cells compared to background). NS indicates non-specific
staining (cells inside and outside the SCN were labeled with the same intensity).
‘‘n.d.’’ indicates not determined.
doi:10.1371/journal.pone.0035938.t001
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Per1
2/2 mice.
The GP91 antibody provided optimal staining in the SCN at
ZT 12 when used at 1:10,000. Staining was much paler at ZT0
except for a few cells in the central SCN. No staining was detected
in Per1
2/2 mice. Higher concentrations of primary antibody
produced more background staining for both R43 and GP91.
PER2. Three of the antibodies to PER2, namely R38, R39 and
GP88worked well. Used at 1:5,000, eachof these antiseraproduced
strong signal in SCN cells at ZT 12, with pale staining at ZT0 in
wild-type mice and no staining in Per2
2/2 mice at ZT 12. For R38
and R39 at ZT0, there were a few cells in the central SCN, while
R39 and GP88 produced very pale cellular staining just outside the
SCN. Higher concentrations produced more background staining
Table 2. Summary of Immunostaining Results in Wild-type and Mutant Mice.
Antibody Wild-type (Peak) Wild-type (Nadir) Mutant (Peak)
Antigen Host Dilution N Staining N Staining N Staining
PER1 R43 1:5,000 4 +++ 3 + 2 2
PER1 GP91 1:10,000 3 +++ 2 + 2 2
PER2 R38 1:5,000 4 +++ 2 + 2 2
PER2 R39 1:5,000 5 +++ 2 + 2 2
PER2 GP87 1:10,000 3 +++ 2 +++ 4 +++
PER2 GP88 1:5,000 5 ++ 2 + 2 2
BMAL1 R36 1:5,000 4 NS 2 NS 1 2
BMAL1 R37 1:5,000 4 +++ 2 + 1 2
BMAL1 GP85 1:5,000 4 +++ 2 + 1 2
BMAL1 GP86 1:10,000 4 +++ 2 + 1 2
CLOCK R40 1:5,000 3 + 2 + 2 2
CLOCK R41 1:5,000 4 +++ 2 +++ 2 2
Host #: R=rabbit; GP=guinea pig. Wild-type mice were perfused at the time of expected peak of immunostaining (ZT12 for PER1 and PER2; ZT0 for BMAL1), and at the
expected low point (nadir) of immunostaining rhythms (ZT0 for PER1, PER2, and ZT12 for BMAL1). Mutant mice were examined at the time of peak staining in wild-type
mice. Results from wild-type mice at peak time are reproduced from Table 1, for comparison. CLOCK immunostaining was comparable at ZT12 (arbitrarily called Peak
Time) and ZT0 (arbitrarily called Nadir Time). CLOCK-deficient mice were examined at ZT12. N=number of animals tested. Results are scored as described in Table 1:
2(no SCN cells labeled), +(relatively poor staining), ++(good staining in SCN), and +++(best staining of SCN cells compared to background). NS indicates non-specific
staining (cells inside and outside the SCN were labeled with the same intensity).
doi:10.1371/journal.pone.0035938.t002
Table 3. Summary of Immunostaining Results in Hamsters.
Antibody Dilution Studies in Hamsters at Peak Time Nadir Time
Antigen Host Peak Time N 1:500 1:1,000 1:5,000 1:10,000 N Staining
PER1 R43 ZT12 3 ++ ++ +++ n.d. 3 +
PER1 R1177 ZT12 3 n.d. n.d. +++ n.d. 0 n.d.
PER1 GP91 ZT12 4 n.d. ++ + + + 2 +
PER2 R38 ZT12 5 22 2 n.d. 0 n.d.
PER2 R39 ZT12 4 22 2 n.d. 0 n.d.
PER2 GP87 ZT12 3 n.d. +++ + + 2 +
PER2 GP88 ZT12 4 n.d. 222 0 n.d
BMAL1 R36 ZT0 3 22 2 n.d. 0 n.d.
BMAL1 R37 ZT0 2 n.d. ++ +++ ++ 2 +
BMAL1 GP85 ZT0 4 + + ++ ++ 3 +
BMAL1 GP86 ZT0 3 NS NS NS NS 3 NS
CLOCK R40 ZT12 3 NS NS NS n.d. 2 NS
CLOCK R41 ZT12 3 ++ + + + + n.d. 3 +++
Host #: R=rabbit; GP=guinea pig. Peak Time: Hamsters were perfused at the time of expected peak of immunostaining and a series of dilutions was examined. Nadir
Time: Hamsters were perfused at the expected low point of immunostaining rhythms (ZT0 for PER1, PER2, and ZT12 for BMAL1). CLOCK immunostaining was
comparable at ZT0 and ZT12; dilution studies were conducted at ZT12 and results from ZT0 are listed arbitrarily as Nadir Time. Studies at nadir time used the antibody
concentration found to give optimal labeling at the peak time. N=number of animals tested. Results are scored as Described in Table 1: 2(no SCN cells labeled),
+(relatively poor staining), ++(good staining in SCN), and +++(best staining of SCN cells compared to background). NS indicates non-specific staining (cells inside and
outside the SCN were labeled with the same intensity). ‘‘n.d.’’ indicates not determined.
doi:10.1371/journal.pone.0035938.t003
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good signal but with higher background; at 1:10,000, SCN cells
were paler and barely distinguishable from peri-SCN areas.
Labeling with antibody GP87 was not specific: GP87 gave strong
immunostaining at both ZT12 and ZT0 and staining was present
even in the SCN of mPer2
2/2 mice (Fig. 1, bottom row).
Figure 1. Photomicrographs of mouse SCN sections immunostained with PER1 and PER2 antibodies. The left column shows sections
from wild-type mice euthanized at ZT12. The center column shows sections from wild-type mice euthanized at ZT0. The right column shows sections
from mice lacking the target antigen (‘‘mutant’’) at ZT12. The antigen, host number (R=rabbit; GP=guinea pig) and antibody concentration used for
each antibody is indicated. Scale bar, 100 mm.
doi:10.1371/journal.pone.0035938.g001
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GP 86 worked well (Fig. 2) while R36 gave no staining at any
concentration used (Tables 1, 2). R37 and GP85 at 1:5,000 and
GP86 at 1:10,000 strongly stained SCN cells at ZT 0 and
produced very pale SCN staining at ZT12. No staining was
detected in Bmal1
2/2 mice with any of these antisera. Addition-
ally, all three antibodies produced pale cellular staining just outside
the SCN at ZT0. For R37, concentration of 1:500 gave high
background; 1:1,000 and 1:5,000 gave comparable results
(Table 1). GP 85 gave high background staining at 1:1,000 and
paler staining at 1:10,000. GP86 gave high background staining at
1:1,000 and 1:5,000.
CLOCK. Antibody R41 worked well (Fig. 2). R41 used at
1:5,000 strongly stained SCN cells at both ZT 12 and ZT 0. Cells
in the peri-SCN were visible but paler than in SCN. R41 used at
1:500 produced good staining of SCN cells, but background cells
in the rest of the brain were also visible. The background brain
cells were paler with 1:1,000 and very pale with 1:5,000. No
staining was detected in Clock
2/2 mice.
Figure 2. Photomicrographs of mouse SCN sections immunostained with BMAL1 and CLOCK antibodies. The left column shows
sections from wild-type mice euthanized at ZT12. The center column shows sections from wild-type mice euthanized at ZT0. The right column shows
sections from mice lacking the target antigen (‘‘mutant’’) at ZT0 or 12, as indicated. The antigen, host number (R=rabbit; GP=guinea pig) and
antibody concentration used for each antibody is indicated. Scale bar, 100 mm.
doi:10.1371/journal.pone.0035938.g002
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and staining was paler still at 1:5,000 at both ZT 12 and ZT 0. At
1:500, background staining was high. No staining was detected in
Clock
2/2 mice (Fig. 2, bottom row).
Antibodies Labeling Hamster SCN
PER1. Both R43 and GP 91 antibodies worked well in
hamster, with very strong SCN cellular labeling and pale peri-
SCN cells staining at 1:5,000 at ZT 12, and paler staining at ZT 0
(Fig. 3, Table 3). At concentrations of 1:500 and 1:1,000, R43 gave
good staining of SCN cells, but with higher background. For
GP91, 1:500 gave good staining for SCN cells, but with high
background while 1:10,000 gave very pale SCN staining.
PER2. In hamster SCN, R38 and GP88 gave no positive
staining at any concentration tested (Table 3). For R39,
concentrations of 1:500, 1:1,000 and 1:5,000 gave poor staining,
and amplification with ABC or ABC+ biotinylated tyramine did
not yield improvements. In contrast to the results in mice, the
GP87 antibody seemed to work well in hamsters (see Discussion
for further consideration of species differences). At 1:10,000 GP87
gave strong immunostaining throughout the SCN at ZT12, and
paler staining at ZT0 (Fig. 3). At concentrations of 1:1,000 and
1:5,000 it gave high background staining (Table 3).
BMAL1. Antibody R37 worked very well, and GP85 gave
good staining in hamster SCN (Fig. 3). R37 stained SCN cells well
at 1:5,000. Pale peri-SCN cells were visible at both ZT0 and at ZT
12. A concentration of 1:1,000 of R37 also gave good staining, but
more extra-SCN cells were visible. A concentration of 1:10,000
produced very pale staining of extra-SCN cells, but also reduced
staining of SCN cells.
GP85 antibody stained SCN cells at 1:10,000, although cells
throughout brain were also labeled, but with somewhat less
intensity than SCN cells at this concentration. Very pale staining
was observed in SCN at ZT 12. The 1:10,000 concentration of
GP85 gave the best difference between SCN and non-SCN cells.
Concentrations of 1:20,000 and 1:40,000 did not eliminate pale
staining of brain cells outside the SCN, but gave reduced SCN
staining.
GP86 stained SCN cells but also all other brain cells with the
same intensity at all concentrations. R36 produced no positive
staining (Table 3).
CLOCK. R41 worked well, while R40 was not specific in
hamster SCN. R41 used at 1:5,000 produced good staining of
SCN cells at both ZT12 and ZT 0. Paler background extra-SCN
cells were also visible. At lower concentrations, SCN cells are well
labeled but were barely distinguishable from the extra-SCN brain
cells. R40 stained all brain cells with similar intensity at both ZT12
and ZT0 (Table 3).
Discussion
The lack of good antibodies makes it difficult to assess the
impact of circadian time, phase shifting stimuli, or clock gene
mutations on clock gene protein products. While there are
commercially available antibodies, many have not been subjected
to validation to assess their usefulness in immunocytochemistry.
Here we generated several antibodies against the clock proteins
PER1, PER2, BMAL1 and CLOCK, and tested them for staining
in the SCN of both mice and hamsters (Tables 1, 2, and 3),
identifying several that gave excellent results (Figs. 1, 2, and 3).
A previously described PER1 antibody, generated in rabbit to
the amino terminus of mouse PER1 (residues 6–21), called 1177,
has been used successfully in many publications [11–15,17,18,20–
35]. This antibody gives good labeling of SCN cells in mouse, and
Figure 3. Photomicrographs of hamster SCN sections immu-
nostained with PER1, PER2, BMAL1 and CLOCK antibodies.
Columns show the staining at ZT12 (left) and ZT0 (right) level for each
antigen. The antigen, host number (R=rabbit; GP=guinea pig) and
antibody concentration used for each antibody is indicated. Scale bar,
100 mm.
doi:10.1371/journal.pone.0035938.g003
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2/2 mice [13]. In the hamster, 1177 stained
SCN cells at about the same intensity as R43 and GP91 when used
at the same concentrations. The 1177 antibody labels cells and
fibers of the magnocellular neurons in the paraventricular and
supraoptic nuclei, as previously described [30], while R43 and
GP91 do not (Fig. 4).
For PER2, R38 and R39 antibodies produced good results in
mouse SCN. Neither of these antibodies worked in hamster SCN.
R38 has also worked in Nile grass rats (Arvicanthis niloticus) [27,36]
and lab rats (Rattus norvegicus) [37,38].
The PER2 antibody GP87 produced non-specific staining in
mouse, as it labeled SCN cells with the same intensity at ZT0 and
12, and staining intensity was not reduced in the SCN of Per2
2/2
mice (Figure 1, Table 2). While GP87 appeared to label hamster
SCN cells strongly at ZT12 and weakly at ZT0, in view of the lack
of specificity seen in mouse, this staining may not be specific to
PER2 (see below for further consideration).
Although PER1 and PER2 expression are higher at ZT12 than
at ZT0, some cells in the central SCN show high PER levels at
ZT0 [11–13]. It may be that these cells express PER constitutively,
or they may express PER in antiphase with the larger population
[39], or the decline in PER expression in these cells may be
delayed relative to the larger population [40].
CLOCK protein is generally thought to be constitutively
expressed in the SCN [15,41], although there is a report indicating
that CLOCK is constitutively expressed in young but rhythmically
expressed in old C57BL/6J mice [42]. Here, R41 worked in both
mouse and hamster where it was highly expressed at both ZT0
and 12, suggesting constitutive expression. Immunostaining of the
mouse SCN, and the absence of staining in Clock
2/2 mice, has
recently been reported by another group using antibody R41 [43].
The previously published evidence for rhythmicity in BMAL1
protein levels is not consistent. Some studies describe rhythmic
BMAL1 protein levels in the SCN, either with a nocturnal peak in
rats (at ZT or CT14–22 in Wistar rats in LD or after 2 or 3 days in
dim red light [44]), or with higher levels in daytime than nighttime
in CD-1 mice in a 12:12 LD cycle [41]. Other studies show no
rhythm of BMAL1 staining in the SCN of C3H/HeJ mice kept for
1 day in dim red light after being in a 12:12 LD cycle [15] or in
young and old C57BL/6J mice [42]. Here, three antibodies to
BMAL1 (R37, GP85, GP86) stained the mouse SCN well, while
two of these antibodies (R37 and GP85) also stained the hamster
SCN. In both species, with each of these antibodies, BMAL1
expression was high at ZT0 and low at ZT12, indicating a rhythm
in BMAL1 in the SCN. Rhythmic expression of Bmal1 RNA levels,
with low levels during mid-day, has been reported in several
studies; the phase of the BMAL1 protein rhythm reported here
seems consistent with the 4–6 hr delay between transcript peak
and protein peak typical of circadian clock proteins [3,4]. Further
analysis of BMAL1 protein rhythms is warranted.
While some antibodies labeled cells in extra-SCN regions, here
we focused on SCN staining, as not all brain regions were tested
for all antibodies and the time of peak expression in extra-SCN
regions differs from the SCN [25–27,45]. Nevertheless, antibodies
producing robust signal in the SCN are likely to be useful for
assessing protein rhythms in other neural sites.
Our systematic comparison of a set of polyclonal antisera to four
key circadian proteins reveals some unexpected differences
between the performance of these antisera in mouse and hamster.
Most notably, three PER2 antisera useful in mouse SCN appear
not to be useful in hamsters. As noted above, one of these PER2
antisera, R38, has been used successfully in the SCN and extra-
SCN regions of Nile grass rats and lab rats [27,36–38]. The single
antibody that produced what appeared to be an SCN-specific
signal with rhythmic labeling in the hamster was GP87. This
antibody produced non-specific labeling in the mouse SCN,
however, raising doubts as to its specificity in hamster as well. This
species difference in PER2 staining with these antisera may be due
to differences in the N-terminal 200 amino acid residues of the
PER2 sequence used as the antigen. A 171-residue amino-terminal
fragment of hamster PER2 [46] has 11 mismatches and requires 3
gaps to align with the mouse sequence it overlaps within the
amino-terminal 200 residues. In contrast, the 200 amino-terminal
residues of Arvicanthis niloticus PER2 align with the mouse sequence
without gaps, and the sequences differ at only 8 residues (96%
identity). Similarly, the lab rat PER2 sequence aligns to the mouse
sequence without gaps and differs at only 7 residues (96.5%
identity). Thus, despite the use of large (200 to 400 residue)
fragments of the circadian proteins as immunogens (intended to
produce a polyclonal response and maximizing the probability of
reactivity in multiple species), the usefulness of these antisera in
other species will need to be examined. Nevertheless, our study
identifies a series of antibodies to these key circadian proteins that
are useful in mice, and which may be useful in other species,
possibly depending on the extent of species conservation of the
amino acid sequences involved. An advantage of these antisera
over some that are commercially available is that the antigens used
here are clearly disclosed, so sequence alignment can be
performed to predict potential reactivity in other species. (Four
antibodies described here, PER1-R1177, PER2-R38, CLOCK-
R41 and BMAL1-GP85 are commercially available through
Millipore Corporation as product numbers AB2201 through
AB2204). A further advantage is our use of genetically modified
mice and two time-points with expected differences in protein
expression levels, allowing functional assessment of the antibodies’
performance. While each lab will need to verify the utility of these
antibodies for their own species of choice and staining protocol,
the results reported here indicate a starting point that should
facilitate other work on immunocytochemical localization of
circadian clock proteins in neural tissues.
Figure 4. Photomicrographs of hamster SCN sections immunostained with PER1 antibodies. PER1 antibodies R1177, R43 and GP91 were
used at a concentration of 1:5,000. Animals were euthanized at ZT12. Scale bar, 100 mm.
doi:10.1371/journal.pone.0035938.g004
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